Sumatriptan Succinate and Naproxen Sodium is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Currax Pharmaceuticals Llc Dba Cypress, Hawthorn, Macoven. The primary component is Sumatriptan Succinate; Naproxen Sodium.
Product ID | 44183-850_01028275-62df-47ab-a2bf-9958bf82eaaf |
NDC | 44183-850 |
Product Type | Human Prescription Drug |
Proprietary Name | Sumatriptan Succinate and Naproxen Sodium |
Generic Name | Sumatriptan Succinate And Naproxen Sodium |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2015-05-14 |
Marketing Category | NDA AUTHORIZED GENERIC / NDA |
Application Number | NDA021926 |
Labeler Name | Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven |
Substance Name | SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM |
Active Ingredient Strength | 85 mg/1; mg/1 |
Pharm Classes | Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-02-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA AUTHORIZED GENERIC |
Application Number | NDA021926 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-02-15 |
Ingredient | Strength |
---|---|
SUMATRIPTAN SUCCINATE | 85 mg/1 |
SPL SET ID: | 5762bbe6-bddf-495c-adf8-9096f98a3a9c |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
44183-850 | Sumatriptan Succinate and Naproxen Sodium | sumatriptan succinate and naproxen sodium |
21695-954 | TREXIMET | sumatriptan succinate and naproxen sodium |
42847-850 | Treximet | Sumatriptan Succinate and Naproxen Sodium |
65224-850 | Treximet | Sumatriptan Succinate and Naproxen Sodium |
65224-860 | Treximet | Sumatriptan Succinate and Naproxen Sodium |